Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e., Monday, 24th February, 2025 at the registered office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, Gujarat, India - 380 055 which commenced at 04:00 P.M. and concluded at 04:30 P.M. inter-alia has, considered and approved 1. Raising of funds upto Rs. 99.99 Crores (Rupees Ninety-Nine Crores and Ninety-Nine Lakhs Only) by way of issue of Warrants (hereinafter referred to as 'Convertible Warrants'), through preferential allotment to the person(s)/ entity(ies) belonging to 'Promoter and Promoter Group Category' and 'Non-Promoter category', as per Chapter V of SEBI (ICDR) Regulations, 2018, subject to approval of Shareholders and other authorities concerned.
Dipna Pharmachem Limited Press Release Feb 24 2025
Filed with BSE · · 3 pages · English
Release
Dipna Pharmachem Limited on 6ix
Earlier from Dipna Pharmachem
- Dipna Pharmachem Limited Press Release Feb 11 2025
- Dipna Pharmachem Limited Press Release Feb 06 2025
- Dipna Pharmachem Limited Press Release Jan 30 2025
- Dipna Pharmachem Limited Press Release Jan 13 2025
- Dipna Pharmachem Limited Press Release Dec 30 2024
Later from Dipna Pharmachem
- Dipna Pharmachem Limited Press Release Mar 07 2025
- Dipna Pharmachem Limited Press Release Mar 12 2025
- Dipna Pharmachem Limited Press Release Mar 13 2025
- Dipna Pharmachem Limited Press Release Mar 29 2025
- Dipna Pharmachem Limited Press Release Apr 04 2025
Follow Dipna Pharmachem into a list and get an email when it puts out news.
Follow Dipna Pharmachem